The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis

There have been many clinical questions regarding whether the use of proton pump inhibitors (PPIs) could deteriorate the effects of cyclin-dependent kinase inhibitors (CDKIs) in HR+/HER2- advanced breast cancer patients. We performed a systematic review and meta-analysis of this clinical question, i...

Full description

Bibliographic Details
Main Authors: Yu-Cheng Chang, Junmin Song, Yu Chang, Chin-Hsuan Huang, Aarushi Sudan, Pei-Chin Chen, Kuan-Yu Chi
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
Palbociclib
Ribociclib
proton pump inhibitor (PPI)
advanced breast cancer
survival rate
Online Access:https://www.mdpi.com/2072-6694/15/21/5133

Internet

https://www.mdpi.com/2072-6694/15/21/5133

Similar Items